Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Sarcoma 10Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Ovarian Neoplasms 4Lymphoma, Non-Hodgkin 4Lung Neoplasms 4Leukemia 4Carcinoma, Non-Small-Cell Lung 4Testicular Neoplasms 3Small Cell Lung Carcinoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neuroblastoma 3Hodgkin Disease 3Central Nervous System Neoplasms 3Testicular Germ Cell Tumor 2Relapsed Pediatric Solid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, T-Cell, Peripheral 2Fallopian Tube Neoplasms 2Burkitt Lymphoma 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Uterine Cervical Neoplasms 1Unresectable Sinonasal Tumors 1Teratoma 1Subcutaneous panniculitis-like T-cell lymphoma 1Spinal Cord Neoplasms 1Sinonasal Tumors 1Seminoma 1

Interventions

N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 14Cyclophosphamide 9Prednisone 8Etoposide 6Vincristine 5Gemcitabine 5Lenalidomide 4Doxorubicin 4Dexamethasone 3Azacitidine 3liposomal doxorubicin 2endostar protein 2apatinib 2VAP-cyclo protocol 2Ifosfamide 2Cisplatin 2sintilimab 1romidepsin 1ivarmacitinib 1fludarabine phosphate 1fludarabine 1camrelizumab 1Vinorelbine 1Valproic Acid 1Transplantation, Autologous 1TQ-B3525 1Rituximab 1Prednisolone 1Polymerase Chain Reaction 1Oxaliplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Lymphoma, T-Cell, Peripheral × Ifosfamide × Clear all
NCT02445404 2020-10-22

Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL

Samsung Medical Center

Phase 2 Unknown
134 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

NCT03071822 2018-06-11

Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell Lymphomas

The University of Hong Kong

Phase 4 Unknown
50 enrolled
Lymphoid

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡